Ultragenyx Pharmaceutical (RARE) Consolidated Net Income (2013 - 2026)
Ultragenyx Pharmaceutical's Consolidated Net Income came in at -$92 million for Q2 2026, compared with -$115 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Consolidated Net Income (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ultragenyx Pharmaceutical reported Consolidated Net Income of -$585.97 million; for FY2025, it was -$575 million.
- Going back by year, Consolidated Net Income was -$569 million in FY2024, -$607 million in FY2023, -$707.42 million in FY2022 and -$454.03 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Consolidated Net Income since Q3 2021.
- Business Quant data shows RARE's Consolidated Net Income at -$185 million (Q1 2026), -$128.56 million (Q4 2025) and -$180.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | -92.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -92.00 Mn |
| Mar 31, 2026 | -185.00 Mn |
| Dec 31, 2025 | -128.56 Mn |
| Sep 30, 2025 | -180.41 Mn |
| Jun 30, 2025 | -115.00 Mn |
| Mar 31, 2025 | -151.00 Mn |
| Dec 31, 2024 | -133.20 Mn |
| Sep 30, 2024 | -133.52 Mn |
| Jun 30, 2024 | -131.60 Mn |
| Mar 31, 2024 | -170.68 Mn |
| Dec 31, 2023 | -123.55 Mn |
| Sep 30, 2023 | -159.65 Mn |
| Jun 30, 2023 | -159.83 Mn |
| Mar 31, 2023 | -163.97 Mn |
| Dec 31, 2022 | -151.83 Mn |
| Sep 30, 2022 | -245.11 Mn |
| Jun 30, 2022 | -158.16 Mn |
| Mar 31, 2022 | -152.32 Mn |
| Dec 31, 2021 | -122.46 Mn |
| Sep 30, 2021 | -73.00 Mn |
API Access
Ultragenyx Pharmaceutical Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();